SEC Form 4 · accession 0000899243-17-019219
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Dougherty
Officer — SVP & Chief Financial Officer
Period of report
Jul 25, 2017
Accepted (ET)
Jul 27, 2017 · 6:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.00 | Jul 25, 2017 | A | 60,331 | A | — | Jul 24, 2027 | Common Stock | 60,331 | 60,331 | D |
Explanation of responses
- F1This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal monthly installments over four years from July 25, 2017.